semaglutide patent expiration semaglutide patent expiry date The Heavy Price of GLP-1 Drugs – I-MAK Ozempic's Patent Protection Starts to

Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins

Study procedures were approved by the University of North Carolina at Chapel Hill Institutional Review Board (IRB #24-1095)

GHK-Cu is known for its wound healing, anti-inflammatory, and collagen-promoting effects, making it a staple in skin repair and dermatology

Because semaglutide reduced the risk of MACE irrespective of baseline kidney function and damage, it is of interest to evaluate if semaglutide can provide consistent effects on hard kidney-related outcomes (kidney failure, 50% decline in eGFR from baseline, or CV or kidney-related death) in the FLOW trial